Rongchuang transferred the equity of Wenzhou No. 1 project company, and the transferee was Dexin real estate
According to industrial and commercial data, rongchuang recently transferred its equity of Wenzhou haokuo Enterprise Management Co., Ltd. to its partner Dexin real estate. The reporter learned that Wenzhou haokuo Enterprise Management Co., Ltd. is a project company. At present, it is developing the "rongchuang Dexin Jiangshan yunqi" project. The plot where the project is located was won by Dexin real estate with a premium rate of 50% at a price of 3.6 billion yuan in June 2020, and then introduced into rongchuang for joint development.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Dec 14, 2020 08:20 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Briefing May 19, 2022 05:45 PM
· Healthcare
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
Financials, Healthcare
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Mar 15, 2022 12:19 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
See more
Read next
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Updated 3 hours ago
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.